Endocrine glands may be involved in patients with thalassemia major. In
the last 20 years, new therapies have significantly improved life
expectancy, while several endocrine abnormalities have been described in
children, adolescents, and young adults suffering from thalassemia
major.
The practical objective of this book is to establish guidelines for the
management of endocrine disorders underlying the various phases of
thalassemic life. Internationally acknowledged experts give a
state-of-the-art account of physiopathological and therapeutical
approaches to endocrine disorders in thalassemia and focus on such
topics as growth hormones, thyroid diseases, puberty, hypogonadism,
diabetes, and bone metabolism.